This webinar took place on October 6th, 2020 Fill in this form to access the recording.
WEBINAR ON DEMAND
SP3 meets iST: Automated sample preparation with SP3 for reproducible proteomics in biology and the clinic
Hear from SP3 inventor Prof. Dr. Jeroen Krijgsveld about improved proteomics sample preparation
Take part and discover!
PreOmics are proud to announce that we have acquired the world wide exclusive license to the SP3 technology and associated patents. The SP3 technology is a perfect complement to the PreOmics iST sample processing technology as a manual workflow or fully automated on our ultra-efficient PreON platform. Together SP3 + iST now set the standard for protein analysis
The technology was developed in the lab of Jeroen Krijgsveld within the framework of EMBL’s interdisciplinary postdoctoral program (EIPOD) and allows for ultrasensitive, rapid, unbiased and flexible sample preparation for proteomic analysis.
SP3 not only overcomes current limitations in proteomics sample preparation such as substantial loss of material, but is also ideally suited for automation. The acquired technology will perfectly complement PreOmics’ streamlined workflows for sample preparation, simplifying increased sample throughput and improved quality for the production of reliable data to customers worldwide.
Discover why SP3 + iST can be a winning combination in your laboratory.
What can you expect?
- 5 min - SP3 meets iST by Dr Garwin Pichler
- 30 min - Presentation by Prof Dr Jeroen Krijgsveld: Automated sample preparation with SP3 for reproducible proteomics in biology and the clinic
- 15 min - Q&A session
Your questions answered by experts:
Prof. Dr. Jeroen Krijgsveld - Division Head, Heidelberg University
Jeroen is full Professor and Head of Division, Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), and Heidelberg University Medical Faculty, Cluster of Excellence CellNetworks
Dr. Garwin Pichler - Founder and CEO at PreOmics
Dr. Garwin Pichler is co-founder and CEO here at PreOmics. Garwin holds a PhD in Biochemistry from the LMU Munich (Germany). Garwin joined Nils Kulak working on the iST Technology in the Matthias Mann lab. Together they founded PreOmics in 2016 and Garwin is responsible for Finances, Business Development, Investor Relationship and HR.